MRS2179 (ammonium salt hydrate) |
A competitive purinergic P2Y1 receptor antagonist (Kb = 102 nM); selective… |
1 mg |
10011450-1 |
More Info
|
MRS2179 (ammonium salt hydrate) |
A competitive purinergic P2Y1 receptor antagonist (Kb = 102 nM); selective… |
10 mg |
10011450-10 |
More Info
|
MRS2179 (ammonium salt hydrate) |
A competitive purinergic P2Y1 receptor antagonist (Kb = 102 nM); selective… |
5 mg |
10011450-5 |
More Info
|
MRT10 |
An antagonist of the Smo receptor (IC50 = 0.64 µM in a luciferase re… |
1 mg |
22138-1 |
More Info
|
MRT10 |
An antagonist of the Smo receptor (IC50 = 0.64 µM in a luciferase re… |
10 mg |
22138-10 |
More Info
|
MRT10 |
An antagonist of the Smo receptor (IC50 = 0.64 µM in a luciferase re… |
25 mg |
22138-25 |
More Info
|
MRT10 |
An antagonist of the Smo receptor (IC50 = 0.64 µM in a luciferase re… |
5 mg |
22138-5 |
More Info
|
MRT68921 |
An inhibitor of ULK1 and ULK2 (IC50s = 2.9 and 1.1 nM, respectively); bloc… |
1 mg |
19905-1 |
More Info
|
MRT68921 |
An inhibitor of ULK1 and ULK2 (IC50s = 2.9 and 1.1 nM, respectively); bloc… |
10 mg |
19905-10 |
More Info
|
MRT68921 |
An inhibitor of ULK1 and ULK2 (IC50s = 2.9 and 1.1 nM, respectively); bloc… |
25 mg |
19905-25 |
More Info
|
MRT68921 |
An inhibitor of ULK1 and ULK2 (IC50s = 2.9 and 1.1 nM, respectively); bloc… |
5 mg |
19905-5 |
More Info
|
MRT67307 (hydrochloride) |
A kinase inhibitor that inhibits TBK1, MARK1-4, IKKε, and NUAK1 (I… |
1 mg |
19916-1 |
More Info
|
MRT67307 (hydrochloride) |
A kinase inhibitor that inhibits TBK1, MARK1-4, IKKε, and NUAK1 (I… |
10 mg |
19916-10 |
More Info
|
MRT67307 (hydrochloride) |
A kinase inhibitor that inhibits TBK1, MARK1-4, IKKε, and NUAK1 (I… |
25 mg |
19916-25 |
More Info
|
MRT67307 (hydrochloride) |
A kinase inhibitor that inhibits TBK1, MARK1-4, IKKε, and NUAK1 (I… |
5 mg |
19916-5 |
More Info
|
MRTX-1133 |
An inhibitor of K-RasG12D; selectively reduces ERK phosphorylation in AsPC… |
1 mg |
36413-1 |
More Info
|
MRTX-1133 |
An inhibitor of K-RasG12D; selectively reduces ERK phosphorylation in AsPC… |
10 mg |
36413-10 |
More Info
|
MRTX-1133 |
An inhibitor of K-RasG12D; selectively reduces ERK phosphorylation in AsPC… |
5 mg |
36413-5 |
More Info
|
MRTX-1257 |
A covalent inhibitor of K-RasG12C; inhibits proliferation of NCI H358 cell… |
1 mg |
33527-1 |
More Info
|
MRTX-1257 |
A covalent inhibitor of K-RasG12C; inhibits proliferation of NCI H358 cell… |
10 mg |
33527-10 |
More Info
|
MRTX-1257 |
A covalent inhibitor of K-RasG12C; inhibits proliferation of NCI H358 cell… |
25 mg |
33527-25 |
More Info
|
MRTX-1257 |
A covalent inhibitor of K-RasG12C; inhibits proliferation of NCI H358 cell… |
5 mg |
33527-5 |
More Info
|
MRTX-849 |
A covalent inhibitor of K-RasG12C; binds to and stabilizes GDP-bound inact… |
1 mg |
31440-1 |
More Info
|
MRTX-849 |
A covalent inhibitor of K-RasG12C; binds to and stabilizes GDP-bound inact… |
10 mg |
31440-10 |
More Info
|
MRTX-849 |
A covalent inhibitor of K-RasG12C; binds to and stabilizes GDP-bound inact… |
5 mg |
31440-5 |
More Info
|
MRTX-0902 |
An inhibitor of the SOS1-K-RasG12C protein-protein interaction (Ki = 1.9 n… |
1 mg |
38578-1 |
More Info
|
MRTX-0902 |
An inhibitor of the SOS1-K-RasG12C protein-protein interaction (Ki = 1.9 n… |
10 mg |
38578-10 |
More Info
|
MRTX-0902 |
An inhibitor of the SOS1-K-RasG12C protein-protein interaction (Ki = 1.9 n… |
25 mg |
38578-25 |
More Info
|
MRTX-0902 |
An inhibitor of the SOS1-K-RasG12C protein-protein interaction (Ki = 1.9 n… |
5 mg |
38578-5 |
More Info
|
MRX-2843 |
A Mer and FLT3 inhibitor (IC50s = 1.3 and 1 nM, respectively); inhibits Ax… |
1 mg |
27923-1 |
More Info
|
MRX-2843 |
A Mer and FLT3 inhibitor (IC50s = 1.3 and 1 nM, respectively); inhibits Ax… |
10 mg |
27923-10 |
More Info
|
MRX-2843 |
A Mer and FLT3 inhibitor (IC50s = 1.3 and 1 nM, respectively); inhibits Ax… |
5 mg |
27923-5 |
More Info
|
MS023 |
An inhibitor of type I PRMTs (IC50s = 30, 119, 83, 4, and 5 nM for PRMT1,… |
10 mg |
34786-10 |
More Info
|
MS023 |
An inhibitor of type I PRMTs (IC50s = 30, 119, 83, 4, and 5 nM for PRMT1,… |
25 mg |
34786-25 |
More Info
|
MS023 |
An inhibitor of type I PRMTs (IC50s = 30, 119, 83, 4, and 5 nM for PRMT1,… |
5 mg |
34786-5 |
More Info
|
MS023 |
An inhibitor of type I PRMTs (IC50s = 30, 119, 83, 4, and 5 nM for PRMT1,… |
50 mg |
34786-50 |
More Info
|
MS-1020 |
A cell-permeable inhibitor of JAK3, strongly inhibiting constitutive autop… |
1 mg |
14273-1 |
More Info
|
MS1943 |
A PROTAC that drives EZH2 degradation; inhibits EZH2 (IC50 = 120 nM) and i… |
1 mg |
35466-1 |
More Info
|
MS1943 |
A PROTAC that drives EZH2 degradation; inhibits EZH2 (IC50 = 120 nM) and i… |
10 mg |
35466-10 |
More Info
|
MS1943 |
A PROTAC that drives EZH2 degradation; inhibits EZH2 (IC50 = 120 nM) and i… |
25 mg |
35466-25 |
More Info
|
MS1943 |
A PROTAC that drives EZH2 degradation; inhibits EZH2 (IC50 = 120 nM) and i… |
5 mg |
35466-5 |
More Info
|
MS-275 |
An inhibitor of HDACs that preferentially inhibits HDAC1 (IC50 = 300 nM) o… |
1 mg |
13284-1 |
More Info
|
MS-275 |
An inhibitor of HDACs that preferentially inhibits HDAC1 (IC50 = 300 nM) o… |
10 mg |
13284-10 |
More Info
|
MS-275 |
An inhibitor of HDACs that preferentially inhibits HDAC1 (IC50 = 300 nM) o… |
25 mg |
13284-25 |
More Info
|
MS-275 |
An inhibitor of HDACs that preferentially inhibits HDAC1 (IC50 = 300 nM) o… |
5 mg |
13284-5 |
More Info
|
MS37452 |
A competitive inhibitor of CBX7 chromodomain binding to H3K27me3 (Ki = 43… |
1 mg |
17533-1 |
More Info
|
MS37452 |
A competitive inhibitor of CBX7 chromodomain binding to H3K27me3 (Ki = 43… |
10 mg |
17533-10 |
More Info
|
MS37452 |
A competitive inhibitor of CBX7 chromodomain binding to H3K27me3 (Ki = 43… |
25 mg |
17533-25 |
More Info
|
MS37452 |
A competitive inhibitor of CBX7 chromodomain binding to H3K27me3 (Ki = 43… |
5 mg |
17533-5 |
More Info
|
MSA-2 |
A STING agonist; binds to wild-type and HAQ variant STING in a 3H-cGAMP fi… |
1 mg |
30140-1 |
More Info
|